New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.

By M. Zile, D. Brutsaert. Circulation, 2002

1,250 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mechanisms of diabetic complications. (2013, background): “Diastolic dysfunction is observed in up to 40–60% of subjects with heart failure (32, 689, 690), with diabetic individuals overrepresented (348).”
Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study (2004, neutral): “Systolic BP, mm Hg 124 (25) 124 (23) 121 (25) 123 (25) 122 (26) 0.”
New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. (2002, background): “The myocardial ECM is composed of 3 important constituents: (1) fibrillar protein, such as collagen type I, collagen type III, and elastin; (2) proteoglycans; and (3) basement membrane proteins, such as collagen type IV, laminin, and fibronectin.”
Irbesartan in patients with heart failure and preserved ejection fraction. (2008, neutral): “Left ventricular hypertrophy 624 ( 30 ) 636 (31)”
Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure (2006, neutral): “Discussion A comparative analysis of LV myocardium in SHF and DHF revealed the following: (1) MyD is larger in DHF, but CVF is similar.”